ENB Therapeutics Company
ENB Therapeutics develops therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.
Employee Number:
1-10
Funding Status:
Early Stage Venture
Headquarters:
New York, New York, United States
Technology:
Immunotherapy
Estimated Revenue:
Less than $1M
Founded Date:
2015
Industry:
PharmTech